| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KOTON
|
12.38 | 10.3B | 5.69 | 2.55 | 2.33 | 21.7% | 39.7% | 73 | 35 | 23.57 | +65.1% | 66 | 0.92 |
|
VAKKO
|
65.50 | 10.5B | 100.00 | 1.07 | 4.00 | 3.2% | 38.9% | 54 | 45 | 83.65 | +19.9% | 73 | 0.20 |
|
SUWEN
|
6.78 | 2.7B | — | 1.78 | 3.61 | 8.8% | 32.3% | 40 | 27 | 7.14 | +3.1% | 44 | 1.55 |
|
RODRG
|
27.28 | 773.1M | 100.00 | 11.11 | 190.79 | 16.6% | 44.8% | 34 | 20 | 13.81 | -35.6% | 73 | 0.11 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.